German biotechnology company BioNTech has received a notice from the US National Institutes of Health (NIH) regarding a default on COVID vaccine royalties. The notice pertains to an agreement between BioNTech and the NIH for the development of a COVID-19 vaccine.
According to the notice, BioNTech has failed to make royalty payments to the NIH as required under the terms of the agreement. The NIH has raised concerns about this default and has requested that BioNTech address the issue promptly.
